Our Science
Nucleos(t)ides
Pipeline & Programs
Hepatitis C
Bemnifosbuvir + Ruzasvir
About Hepatitis C
About Atea
About Us
Leadership
Careers
Contact
Investors
Overview
News & Events
News Releases
Events & Presentations
Publications
Financials
SEC Filings
Annual Reports
Quarterly Reports
Stock Info
Stock Quote & Chart
Historical Price Look Up
Analyst Coverage
Corporate Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
Shareholder Resources
Investor FAQS
Email Alerts
Contact IR
RSS Feeds
BREAKING NEWS
Atea Pharmaceuticals announces strategic collaboration with Roche to develop and commercialize AT-527 for patients with COVID-19.
Read More
Enter Site